To determine whether this phenomenon participates in gemcitabine resistance in cervical cancer, the deacetylase activity was measured in CaLo cells using a kit which contains the prototype HDAC inhibitor trichostatin A as a positive control. This evidence concerns the gene HDAC9 and cervical carcinoma.